Growth factors in corneal transplant surgery
Part of Eyes & vision, Genetic & congenital clinical trials.
This study tests whether adding a special growth factor solution to the fluid used during corneal transplant surgery helps the transplant heal better. It is for patients undergoing a specific type of corneal transplant called DSEK or DMEK.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having a DSEK or DMEK corneal transplant at Bascom Palmer Eye Institute or Price Vision Group.
- The donor cornea has been preserved for less than 14 days.
- Your vision in the other eye is 20/40 or better (can read the big 'E' on the eye chart).
- You have not had a previous corneal transplant in the same eye.
- You have not had any eye surgeries other than cataract surgery (for example, no glaucoma drainage tubes or silicone oil).
- You are not taking medications that suppress your immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a specific type of cornea transplant (called endothelial lamellar transplant) for people with Fuchs disease or other causes of corneal swelling that affect vision. It aims to see whether this surgical approach improves outcomes and quality of life after surgery.
This Phase 3 trial compares outcomes from two cornea transplant procedures in people with FECD, a disease that makes the cornea swell and affect vision. It may help you and others by identifying which approach best supports clear vision and stable corneal thickness after surgery.
This trial tests a new corneal implant to treat corneal swelling caused by Fuchs' dystrophy or after cataract surgery. It aims to improve vision and reduce the need for a full corneal transplant.
This trial tests a new way to perform a corneal transplant (DSAEK) using a laser to prepare the donor tissue. It may help people with Fuchs' dystrophy or certain types of corneal swelling, but not those with glaucoma, scarring, or other eye diseases.
This trial looks at how to manage medicine around DMEK corneal transplant surgery to improve eye outcomes and safety. It may help people having this specific type of cornea transplant by testing an approach in the time after surgery.
This trial tests a new treatment, EO2002, for people with corneal swelling that causes vision loss. It aims to offer an alternative to corneal transplant for those with conditions like Fuchs dystrophy or swelling after cataract surgery.
Hear when a new Fuchs' Endothelial Dystrophy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.